In the previous paper {Ookata et al., (1997) Biochemistry, 36: 249-259}, we
identified two mitotic cdc2 kinase phosphorylation sites (Ser696 and Ser78
7) in the proline-rich region of human MAP4. One (Ser696) of them was also
phosphorylated during interphase. A protein kinase responsible for interpha
se phosphorylation of Ser696 could necessarily be distinct from cdc2/cyclin
B kinase, To get insights into a physiological role for Ser696 phosphoryla
tion, we searched for a Ser696 kinase and for cellular conditions under whi
ch Ser696 is dephosphorylated. Because Ser696 conforms to the MAP kinase ph
osphorylation consensus motif (PXSP), MAP kinase was tested as a possible k
inase phosphorylating Ser696. MAP kinase, in fact, did phosphorylate Ser696
in MTB3, the carboxy-terminal half of human MAP4 in vitro. Phosphorylation
of Ser696 in HeLa cell extract was suppressed by a MAP kinase inhibitor, D
BTM-0004. Also consistent with the notion that Ser696 is a MAP kinase site
were the fact that serum-starvation induced dephosphorylation of Ser696 in
HeLa cells, TIG-3 and MRC-5-30 human fibroblasts, while readdition of serum
recovered Ser696 phosphorylation, albeit after a surprisingly long interva
l. Thus, phosphorylation of Ser696 of MAP4, most likely carried out by MAP
kinase, may play a role in modulation of MAP4 activity in proliferating ver
sus quiescent cells.